SCHEMBL19984763

SCHEMBL19984763

O=C1Nc2cnccc2Sc2ccccc21

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.68
ALDH1A1 P00352 2/20 0.56
ALOX15 P16050 2/20 0.56
MAPK10 P53779 1/20 0.56
HSD17B10 Q99714 1/20 0.56
MAPT P10636 9/20 0.53
GAA P10253 3/20 0.53
IDO1 P14902 1/20 0.53
MAPK1 P28482 2/20 0.49
TSHR P16473 1/20 0.49
HPGD P15428 2/20 0.47
POLB P06746 3/20 0.43
TDP1 Q9NUW8 3/20 0.43
TP53 P04637 5/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
RXFP1 Q9HBX9 1/20 0.43
CYP1A2 P05177 2/20 0.41
PDGFRA P16234 1/20 0.41
FER P16591 1/20 0.41
LTK P29376 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8988 0.81 L3MBTL1 (1.00) L3MBTL1ALDH1A1ALOX15MAPK10HSD17B10
SCHEMBL7888523 0.80 MAPT (0.79) L3MBTL1ALDH1A1ALOX15HSD17B10MAPT
SCHEMBL17059746 0.75 L3MBTL1 (0.58) L3MBTL1ALDH1A1ALOX15MAPK10HSD17B10
SCHEMBL2509785 0.72 ACVR1 (0.69) L3MBTL1ALDH1A1HSD17B10MAPTGAA
SCHEMBL9178250 0.72 ALDH1A1 (1.00) L3MBTL1ALDH1A1ALOX15MAPK10HSD17B10
SCHEMBL17085948 0.72 L3MBTL1 (0.68) L3MBTL1ALDH1A1ALOX15MAPK10HSD17B10
SCHEMBL2113682 0.72 L3MBTL1 (0.68) L3MBTL1ALDH1A1ALOX15MAPK10HSD17B10
SCHEMBL29441713 0.72 L3MBTL1 (0.68) L3MBTL1ALDH1A1ALOX15MAPK10HSD17B10
SCHEMBL3190862 0.72 L3MBTL1 (0.68) L3MBTL1ALDH1A1ALOX15MAPK10HSD17B10
SCHEMBL5057716 0.72 L3MBTL1 (0.68) L3MBTL1ALDH1A1ALOX15MAPK10HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220023311-A1 HEPATITIS B CORE PROTEIN MODULATORS ASSEMBLY BIOSCIENCES INC (US) 2022-01-27 US disclosed
US-20220023311-A1 HEPATITIS B CORE PROTEIN MODULATORS ASSEMBLY BIOSCIENCES INC (US) 2022-01-27 US disclosed
US-10987360-B2 Hepatitis B core protein modulators ASSEMBLY BIOSCIENCES, INC. (US) 2021-04-27 US disclosed
US-10987360-B2 Hepatitis B core protein modulators ASSEMBLY BIOSCIENCES, INC. (US) 2021-04-27 US disclosed
US-20190255067-A1 HEPATITIS B CORE PROTEIN MODULATORS ASSEMBLY BIOSCIENCES INC (US) 2019-08-22 US disclosed
US-20190255067-A1 HEPATITIS B CORE PROTEIN MODULATORS ASSEMBLY BIOSCIENCES INC (US) 2019-08-22 US disclosed
WO-2018053157-A1 HEPATITIS B CORE PROTEIN MODULATORS ASSEMBLY BIOSCIENCES, INC. (US) 2018-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10987360-B2 Hepatitis B core protein modulators HAVCR2, FABP1, MAVS L3MBTL1 2994/4885ALDH1A1 3992/4885ALOX15 3298/4885
US-20190255067-A1 HEPATITIS B CORE PROTEIN MODULATORS HAVCR2, FABP1, MAVS L3MBTL1 2994/4885ALDH1A1 3992/4885ALOX15 3298/4885
US-20220023311-A1 HEPATITIS B CORE PROTEIN MODULATORS HAVCR2, FABP1, MAVS L3MBTL1 2994/4885ALDH1A1 3992/4885ALOX15 3298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.